JP2013505949A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505949A5
JP2013505949A5 JP2012531061A JP2012531061A JP2013505949A5 JP 2013505949 A5 JP2013505949 A5 JP 2013505949A5 JP 2012531061 A JP2012531061 A JP 2012531061A JP 2012531061 A JP2012531061 A JP 2012531061A JP 2013505949 A5 JP2013505949 A5 JP 2013505949A5
Authority
JP
Japan
Prior art keywords
hydroxy
ethoxy
phenyl
nitrophenyl
dihydropyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012531061A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505949A (ja
JP5775519B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050164 external-priority patent/WO2011038204A1/en
Publication of JP2013505949A publication Critical patent/JP2013505949A/ja
Publication of JP2013505949A5 publication Critical patent/JP2013505949A5/ja
Application granted granted Critical
Publication of JP5775519B2 publication Critical patent/JP5775519B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012531061A 2009-09-25 2010-09-24 S−ニトロソグルタチオンレダクターゼ阻害薬としての新規ジヒドロピリミジン−2(1h)−オン化合物 Expired - Fee Related JP5775519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24585909P 2009-09-25 2009-09-25
US61/245,859 2009-09-25
PCT/US2010/050164 WO2011038204A1 (en) 2009-09-25 2010-09-24 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors

Publications (3)

Publication Number Publication Date
JP2013505949A JP2013505949A (ja) 2013-02-21
JP2013505949A5 true JP2013505949A5 (enExample) 2013-11-07
JP5775519B2 JP5775519B2 (ja) 2015-09-09

Family

ID=43796219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012531061A Expired - Fee Related JP5775519B2 (ja) 2009-09-25 2010-09-24 S−ニトロソグルタチオンレダクターゼ阻害薬としての新規ジヒドロピリミジン−2(1h)−オン化合物

Country Status (4)

Country Link
US (3) US8741915B2 (enExample)
EP (1) EP2480086A4 (enExample)
JP (1) JP5775519B2 (enExample)
WO (1) WO2011038204A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741915B2 (en) 2009-09-25 2014-06-03 N30 Pharmaceuticals, Inc. Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
EP2592934B1 (en) 2010-07-16 2015-08-26 Nivalis Therapeutics, Inc. Novel dihydropyridin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
US8906933B2 (en) 2010-09-24 2014-12-09 N30 Pharmaceuticals, Inc. Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists
CN104418718B (zh) * 2013-08-28 2018-04-13 山东新时代药业有限公司 一种环丙基‑2‑溴‑2‑(2‑氟苯基)乙酮的制备方法
WO2016055947A1 (en) * 2014-10-07 2016-04-14 Glenmark Pharmaceuticals S.A. Alkyne compounds as s-nitrosoglutathione reductase inhibitors
CN104803954B (zh) * 2015-04-30 2018-01-26 上海应用技术学院 一种福沙那韦中间体的制备方法
WO2018011376A1 (en) * 2016-07-13 2018-01-18 Centre National De La Recherche Scientifique - Cnrs - Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines
WO2018054711A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054721A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054723A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018065182A1 (en) 2016-10-04 2018-04-12 Basf Se Reduced quinoline compounds as antifuni agents
WO2018073110A1 (en) 2016-10-20 2018-04-26 Basf Se Quinoline compounds as fungicides

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
CA2218360A1 (en) 1995-05-10 1996-11-14 G.D. Searle & Co. Nitric oxide synthase inhibitors derived from cyclic amidines
US6057367A (en) 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
GB9813271D0 (en) 1998-06-19 1998-08-19 Zeneca Ltd Composition and use
US7049308B2 (en) 2000-10-26 2006-05-23 Duke University C-nitroso compounds and use thereof
US6359182B1 (en) 2000-10-26 2002-03-19 Duke University C-nitroso compounds and use thereof
US7179791B2 (en) 2001-01-11 2007-02-20 Duke University Inhibiting GS-FDH to modulate NO bioactivity
CA2492342C (en) 2002-07-22 2011-03-22 Orchid Chemicals & Pharmaceuticals Ltd. Novel bio-active pyrimidine derivatives
AU2003255492A1 (en) * 2002-09-10 2004-04-30 Bayer Healthcare Ag Heterocyclic derivatives
GB0220961D0 (en) * 2002-09-10 2002-10-23 Bayer Ag Heterocyclic derivatives
US7504382B2 (en) 2003-05-06 2009-03-17 Cytovia, Inc. Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
WO2005000229A2 (en) 2003-06-04 2005-01-06 Duke University Compositions and methods for modulating s-nitrosoglutathione reductase
WO2005054239A1 (en) * 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
FR2883284A1 (fr) 2005-03-15 2006-09-22 Commissariat Energie Atomique Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
EP1731911A1 (fr) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
JP4488963B2 (ja) 2005-06-23 2010-06-23 株式会社Adeka 光学記録材料
WO2007101213A2 (en) * 2006-02-28 2007-09-07 Kalypsys, Inc. Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors
JP5302012B2 (ja) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
RU2329260C1 (ru) 2007-02-20 2008-07-20 Юрий Иосифович Копырин Способ получения 2-анилинопиримидинов или их солей (варианты)
ES2395114T3 (es) 2007-03-27 2013-02-08 Synta Pharmaceuticals Corporation Derivados de triazinona y de diazinona útiles como inhibidores de Hsp90
WO2009019800A1 (ja) 2007-08-06 2009-02-12 Nagoya Industrial Science Research Institute 濾過装置及び濾過方法
WO2009076665A1 (en) * 2007-12-13 2009-06-18 Indiana University Research And Technology Corporation Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
US20110201634A1 (en) 2008-06-13 2011-08-18 Delhi University Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same
DK2318007T3 (da) * 2008-08-15 2013-03-25 N30 Pharmaceuticals Inc Nye pyrrol-inhibitorer af s-nitrosoglutathion-reduktase som terapeutiske midler
WO2010046780A2 (en) * 2008-10-22 2010-04-29 Institut Pasteur Korea Anti viral compounds
WO2010107476A1 (en) 2009-03-19 2010-09-23 Duke University Inhibiting gsnor
US8741915B2 (en) 2009-09-25 2014-06-03 N30 Pharmaceuticals, Inc. Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
EP2592934B1 (en) * 2010-07-16 2015-08-26 Nivalis Therapeutics, Inc. Novel dihydropyridin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
US8906933B2 (en) * 2010-09-24 2014-12-09 N30 Pharmaceuticals, Inc. Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists

Similar Documents

Publication Publication Date Title
JP2013505949A5 (enExample)
JP6862033B2 (ja) Gpr120アゴニストとしてのビアリール誘導体
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
EP0733033B1 (en) Pharmaceutically active substituted aromatic compounds
RU2487713C2 (ru) Фармацевтическая композиция и способ лечения или профилактики физиологических и/или патофизиологических состояний, ассоциированных с ингибированием киназ pi3k, у млекопитающих
US20080058356A1 (en) 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists
JP2010539187A5 (enExample)
JP2013542937A5 (enExample)
JP5494482B2 (ja) トリアゾール誘導体またはその塩
CN110642741A (zh) 作为抗hbv感染的抗病毒剂的官能化苯甲酰胺衍生物
JP5552539B2 (ja) Cns障害の処置のためのオキサゾリン誘導体
JP2010540462A5 (enExample)
HRP20151201T1 (hr) Supstituirani derivati benzamida
JP2006509748A5 (enExample)
JP2007514003A6 (ja) アデノシン受容体アンタゴニストとしての2,6−ビスヘテロアリール−4−アミノピリミジン
US20160024004A1 (en) Novel antiviral agents against hbv infection
WO2009107391A1 (ja) 6員芳香環含有化合物
RU2008136553A (ru) Производные бензотиазола в качестве агонистов бета2 адренорецептора
JP2005523901A (ja) Npyアンタゴニストとしてのキノリン誘導体
JP2006503081A5 (enExample)
JP2013519724A5 (enExample)
HRP20160359T1 (hr) Derivati kinazolindiona, njihovo dobivanje i njihove terapijske primjene
JP2008516902A5 (enExample)
JP2020526547A5 (enExample)
JP2017529346A5 (enExample)